---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-022266"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:05:10.913751+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# X4 Pharmaceuticals stockholders elect three directors and approve all proposals at 2023 annual meeting

## Summary
- Elected Gary J. Bridger, Francoise de Craecker, and Murray W. Stewart as directors for three-year terms.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2023 with 94.3M votes for.
- Advisory vote on named executive officer compensation approved with 59.3M for vs 8.0M against.
- Stockholders preferred a one-year frequency for future say-on-pay votes; board adopted annual votes.
- Approved Amended and Restated 2017 Employee Stock Purchase Plan with 66.7M votes for.

## SEC filing metadata
- accession: 0001628280-23-022266
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828023022266/0001628280-23-022266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828023022266/xfor-20230613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-022266
- JSON: https://secwatch.observer/filing/0001628280-23-022266.json
- Plain text: https://secwatch.observer/filing/0001628280-23-022266.txt

## Key facts
- Shareholder Votes
  X4 Pharmaceuticals, Inc shareholders approved Advisory Vote on the Compensation of the Named Executive Officers at the 2023-06-13 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: The votes cast were as follows: For Against Abstain Broker Non-Votes 59,263,769 7,988,869 175,031 26,939,489
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501697/000162828023022266/0001628280-23-022266-index.htm
- Shareholder Votes
  X4 Pharmaceuticals, Inc shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2023-06-13 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: The votes cast were as follows: For Against Abstain Broker Non-Votes 94,283,872 71,919 11,367 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501697/000162828023022266/0001628280-23-022266-index.htm
- Shareholder Votes
  X4 Pharmaceuticals, Inc shareholders approved Approval of the Company's Amended and Restated 2017 Employee Stock Purchase Plan at the 2023-06-13 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: The votes cast were as follows: For Against Abstain Broker Non-Votes 66,701,613 641,702 84,354 26,939,489
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501697/000162828023022266/0001628280-23-022266-index.htm
- Shareholder Votes
  X4 Pharmaceuticals, Inc shareholders approved Election of Directors at the 2023-06-13 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: The votes cast were as follows: Nominees For Withheld Broker Non-Votes Gary J. Bridger, Ph.D. 60,120,050 7,307,619 26,939,489 Francoise de Craecker 60,283,484 7,144,185 26,939,489 Murray W. Stewart, M.D. 60,138,639 7,289,030 26,939,489
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501697/000162828023022266/0001628280-23-022266-index.htm
- Shareholder Votes
  X4 Pharmaceuticals, Inc shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation at the 2023-06-13 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: The votes cast were as follows: 1 Year 2 Years 3 Years Abstain 60,811,809 6,157,200 396,956 61,704
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501697/000162828023022266/0001628280-23-022266-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.